Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

The prognostic impact of SIGLEC5-induced impairment of CD8 + T cell activation in sepsis

  • Lozano-Rodríguez, Roberto
  • Avendaño-Ortíz, José
  • Montalbán-Hernández, Karla
  • Ruiz-Rodriguez, Juan Carlos|||0000-0001-7392-8617
  • Ferrer, Ricard|||0000-0002-4859-4747
  • Martín-Quirós, Alejandro
  • Maroun-Eid, Charbel
  • González-López, Juanjo|||0000-0003-2419-5909
  • Fàbrega-Santamaria, Anna|||0000-0002-3866-2291
  • Terrón-Arcos, Verónica
  • Gutiérrez-Fernández, María
  • Alonso-López, Elisa
  • Cubillos-Zapata, Carolina
  • Fernández Velasco, María|||0000-0002-3293-3046
  • Perez de Diego, Rebeca|||0000-0001-8426-8765
  • Pelegrín, Pablo|||0000-0002-9688-1804
  • García-Palenciano, Carlos
  • Cueto, Francisco J.
  • del Fresno, Carlos
  • López-Collazo, Eduardo
Sepsis is associated with T-cell exhaustion, which significantly reduces patient outcomes. Therefore, targeting of immune checkpoints (ICs) is deemed necessary for effective sepsis management. Here, we evaluated the role of SIGLEC5 as an IC ligand and explored its potential as a biomarker for sepsis. In vitro and in vivo assays were conducted to both analyse SIGLEC5's role as an IC ligand, as well as assess its impact on survival in sepsis. A multicentre prospective cohort study was conducted to evaluate the plasmatic soluble SIGLEC5 (sSIGLEC5) as a mortality predictor in the first 60 days after admission in sepsis patients. Recruitment included sepsis patients (n = 346), controls with systemic inflammatory response syndrome (n = 80), aneurism (n = 11), stroke (n = 16), and healthy volunteers (HVs, n = 100). SIGLEC5 expression on monocytes was increased by HIF1α and was higher in septic patients than in healthy volunteers after ex vivo LPS challenge. Furthermore, SIGLEC5-PSGL1 interaction inhibited CD8 + T-cell proliferation. Administration of sSIGLEC5r (0.8 mg/kg) had adverse effects in mouse endotoxemia models. Additionally, plasma sSIGLEC5 levels of septic patients were higher than HVs and ROC analysis revealed it as a mortality marker with an AUC of 0.713 (95% CI, 0.656-0.769; p < 0.0001). Kaplan-Meier survival curve showed a significant decrease in survival above the calculated cut-off (HR of 3.418, 95% CI, 2.380-4.907, p < 0.0001 by log-rank test) estimated by Youden Index (523.6 ng/mL). SIGLEC5 displays the hallmarks of an IC ligand, and plasma levels of sSIGLEC5 have been linked with increased mortality in septic patients.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Inflammatory cytokines and organ dysfunction associate with the aberrant DNA methylome of monocytes in sepsis

  • Lorente-Sorolla, Clara|||0000-0003-0404-9453
  • Garcia-Gomez, Antonio
  • Català-Moll, Francesc|||0000-0002-2354-8648
  • Toledano, Víctor
  • Ciudad, Laura|||0000-0002-5219-6792
  • Avendaño-Ortiz, José
  • Maroun-Eid, Charbel
  • Martín-Quirós, Alejandro
  • Martínez Gallo, Mónica|||0000-0002-7340-2161
  • Ruiz-Sanmartín, Adolfo|||0000-0001-5587-5419
  • del Campo, Álvaro García
  • Ferrer, Ricard|||0000-0002-4859-4747
  • Ruiz-Rodriguez, Juan Carlos|||0000-0001-7392-8617
  • Álvarez-Errico, Damiana|||0000-0002-7921-5164
  • Ballestar, Esteban|||0000-0002-1400-2440
Sepsis, a life-threatening organ dysfunction caused by a dysregulated systemic immune response to infection, associates with reduced responsiveness to subsequent infections. How such tolerance is acquired is not well understood but is known to involve epigenetic and transcriptional dysregulation. Bead arrays were used to compare global DNA methylation changes in patients with sepsis, non-infectious systemic inflammatory response syndrome, and healthy controls. Bioinformatic analyses were performed to dissect functional reprogramming and signaling pathways related to the acquisition of these specific DNA methylation alterations. Finally, in vitro experiments using human monocytes were performed to test the induction of similar DNA methylation reprogramming. Here, we focused on DNA methylation changes associated with sepsis, given their potential role in stabilizing altered phenotypes. Tolerized monocytes from patients with sepsis display changes in their DNA methylomes with respect to those from healthy controls, affecting critical monocyte-related genes. DNA methylation profiles correlate with IL-10 and IL-6 levels, significantly increased in monocytes in sepsis, as well as with the Sequential Organ Failure Assessment score; the observed changes associate with TFs and pathways downstream to toll-like receptors and inflammatory cytokines. In fact, in vitro stimulation of toll-like receptors in monocytes results in similar gains and losses of methylation together with the acquisition of tolerance. We have identified a DNA methylation signature associated with sepsis that is downstream to the response of monocytes to inflammatory signals associated with the acquisition of a tolerized phenotype and organic dysfunction.